IJR News — today's news from every side

IJR News — today's news from every side

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

Vertex Lab Combines V2Fun AI With GPT-6 Astra for Editable 3D Assets — 1dVertex Lab showcased a component-based workflow that merges its V2Fun 3D generation with GPT-6 Astra’s planning and coding to turn reference images into assembled, editable 3D assets, preserving major components for later editing. The demos, including an excavator and armored character, use Three.js to assemble parts and add detailed features, highlighting how procedural and hybrid approaches can shape final models.

Elena Vasquez The excavator demo shows real promise for keeping parts separate instead of baking everything into one mesh.

OpenAI Unveils GPT-6 Astra Amid Safety ScrutinyTech — Sep 2, 2026OpenAI is delaying and restricting access to its new Astra model, which has reached a Critical cybersecurity capability rating and can autonomously identify and exploit security flaws, prompting heightened safeguards, monitoring, and a staged rollout to a small group of testers and trusted partners. The company says Astra will be released soon with defensive uses prioritized and ongoing safety testing, after recent incidents and intensified red-teaming prompted new security measures.

OpenAI launches ChatGPT for Financial Services aimed at Wall Street tasks — 2dOpenAI has rolled out ChatGPT for Financial Services, a tailored enterprise product powered by GPT-6 Astra that combines its AI with data from vendors like LSEG, PitchBook, and Daloopa, developed with Morgan Stanley and Evercore as design partners to aid analysts, researchers, and presentation work for Wall Street. The offering emphasizes governance and compliance—role-based access, encryption, and exportable logs—while enabling firms to integrate their existing data subscriptions and extend coverage across multiple sources to improve retrieval, citation, and client-material generation.

Priya Raman This integration with LSEG and PitchBook data could finally cut down the time analysts spend hunting across separate platforms.

Video — YouTubeJon on Trump's Meme Assault on Canada & the Alternate Reality He's Constructed | The Daily ShowThe Daily Show · 8.9M views · Sep 9, 2026

OpenAI Claims AI Solved Navier-Stokes Millennium Problem Amid Credit AllegationsTech — 4dOpenAI has announced breakthroughs claiming solutions to Millennium Prize Problems, including a Navier–Stokes related result produced by AI, though scholars have questioned attribution and raised concerns about credit and originality. The debate expanded as OpenAI’s Astra model allegedly solved 10 longstanding problems at minimal compute cost, attracting criticism over undisclosed prior work and potential research misconduct.

IJRBirth Tourism Is a Loophole. It Is Time To Close It.Rich McCormick · 5 min · 11h

Three Men Killed in Wheathampstead Hertfordshire Two-Vehicle Crash — Jul 23, 2026A two-vehicle crash on Cory Wright Way in Wheathampstead involving a silver Vauxhall Astra and a grey BMW 840i killed three men in their 30s to 50s and left the BMW driver seriously injured, with conditions of the victims and ongoing investigations being reported by multiple outlets; police have appealed for witnesses and dash-cam footage as road closures were lifted.

RankingBest Republican Presidents RankedRepublican presidents have led the United States through civil war, industrial growth, world wars, and economic booms and busts. Their records reveal sharp differences in how they handled national crises and shaped long-term institutions. Vote for your top choice below.750 votes · 18 candidates

Expert WHO Committee To Review AstraZeneca Vaccine After Worrying Side Effects AppearReporting — Mar 14, 2021Even amid concerns that have led an increasing number of countries to stop distributing the COVID-19 vaccine produced by AstraZenecaa, the World Health Organization is urging its continued use. The WHO’s global advisory…

AstraZeneca India CFO Bhavana Agrawal to resignBusiness — Jul 21, 2026AstraZeneca Pharma India said CFO and Whole-Time Director Bhavana Agrawal will resign to take a regional role within the AstraZeneca Group, effective August 31, 2026, with a multi‑week handover and a search for a successor. Regulatory filings confirm the move as part of global realignment, while the company notes strong FY2025-26 growth, including about 33% higher revenue and solid PAT, underscoring ongoing operational resilience.

AstraZeneca Breast Cancer Trial Misses Key Goal — 1dAstraZeneca’s breast cancer pill camizestrant (Etcamah) failed to improve progression-free survival in a late-stage trial when added to standard therapy, despite an earlier ESR1 mutation–targeted approval and after-hours stock weakness. The broader trial that reached more patients failed, while a separate study in ESR1-mutant patients showed a meaningful benefit, underscoring a split outcome for the drug’s potential.

Marcus Bell It's frustrating the overall trial missed but good the ESR1 group still saw real benefit from the drug.

AstraZeneca Ends Phase III Lung Cancer Trial — Aug 17, 2026AstraZeneca reports a setback as its Phase III trial of volrustomig plus chemotherapy in PD-L1 negative metastatic non-small cell lung cancer is halted after an independent data review found it unlikely to meet primary endpoints, while another late-stage study in cervical cancer and other indications continues. In a positive contrast, AZN and partners SAFFRON showed that Tagrisso combined with Orpathys significantly improved progression-free and overall survival, underscoring a mixed near-term outlook but ongoing strength in its immuno-oncology pipeline.

On X · @onenonly_tokyoONE N’ ONLY Announces Major 2nd Album ‘MEGA GOLDEN’J-pop group ONE N’ ONLY (STARDUST PROMOTION / EBiDAN) announced their major 2nd album MEGA GOLDEN releasing December 2, 2026, with lead track “Golden Sun”. The announcement generated strong positive fan engagement and promotional coverage with no opposition.1,248 likes · 7m

AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook — Jul 24, 2026AstraZeneca beat second-quarter profit expectations and reaffirmed its 2026 outlook despite concerns about future growth after a trial setback, as investors await further details on its earnings trajectory. Analysts are mixed but broadly positive, with several buy ratings and a focus on the upcoming Q2 results and oncology-driven revenue, amid a broader market backdrop of cautious trading ahead of earnings.

Video — YouTubeA tactical genius in the stands?! 🤯 #ShortsDistantMoments · 3.6M views · Sep 11, 2026

EU Approves Etcamah in First-Line ER+ Breast Cancer — Jul 23, 2026AstraZeneca’s Etcamah (camizestrant) won EU approval to be used with CDK4/6 inhibitors as a first-line treatment for ER-positive, HER2-negative advanced breast cancer in patients with ESR1 mutations, based on SERENA-6 trial results showing a 56% reduction in progression or death. The drug already has approvals in Japan, the UAE, and Saudi Arabia, with U.S. review ongoing and the EU decision highlighting its potential to expand AstraZeneca’s oncology footprint as it targets endocrine-resistant disease.

VS BattleSoccer vs American FootballThe world's game versus America's obsession — simplicity against spectacle.Soccer vs American Football · 146 votes — pick a side

Coroner Rules Young Doctor Died from Blood Clot Due to COVID Vaccine – Wife Wants Death Certificate ChangedReporting — Apr 24, 2023A London Coroner’s Court has ruled that the blood clot that killed British psychologist Stephen Wright in January 2021 was linked to the AstraZeneca COVID-19 vaccine. The AstraZeneca vaccine is not approved for use in…

AstraZeneca Says US Data Load for US COVID-19 Vaccine Approval Very BigReporting — Apr 30, 2021AstraZeneca is working as fast as possible to compile data on its COVID-19 vaccine to apply for U.S. approval but the dataset is very big, executives said on Friday as the drugmaker faces delays to its submission…

US To Share Up to 60 Million AstraZeneca Vaccine Doses Globally: White HouseReporting — Apr 26, 2021The United States will start to share up to 60 million doses of AstraZeneca Plc’s coronavirus vaccine with other countries as soon as the next few weeks, the White House said on Monday. White House Press Secretary Jen…

Daily Caller News FoundationBirth Tourism Is a Loophole. It Is Time To Close It.American citizenship should never be for sale. Right now, it is.11h · 1 reads

AstraZeneca Shot Is Good If Safety Issues Can Be Overcome, Fauci SaysReporting — Apr 13, 2021U.S. infectious disease official Anthony Fauci said AstraZeneca’s COVID-19 vaccine had good efficacy, but safety concerns needed to be straightened out and it might not be needed for Americans because of supplies of…

QuizWhat's your pet energy?At home, with your guard down, you are an animal. Twelve questions to determine which one.3 min · today's quiz

Investigation Finds ‘Clear’ Link Between AstraZeneca COVID-19 Vaccine and Blood Clots in BrainReporting — Apr 6, 2021A link between AstraZeneca’s COVID-19 vaccine and rare blood clots in the brain has been discovered, but officials have yet to identify a possible cause, according to a senior European Medicines Agency official. “In my…

AstraZeneca Says COVID-19 Vaccine 76 Percent Effective in New Analysis, To Seek US ApprovalReporting — Mar 25, 2021AstraZeneca’s said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial – only a tad lower than the level in an earlier report this week criticised for using outdated data. Interim data published…

Video — YouTubePapoose "Jezebel" Official Music VideoPapoose · 265.9K views · Sep 11, 2026

AstraZeneca US Trial Data a Confidence Booster for COVID-19 ShotReporting — Mar 22, 2021AstraZeneca’s COVID-19 vaccine performed better than expected in a major late-stage trial, potentially paving the way for its emergency authorization in the United States and bolstering confidence in the shot after…

Exclusive: US Plans To Send 4 Million Doses of AstraZeneca Vaccine to Mexico, CanadaReporting — Mar 18, 2021The United States plans to send roughly 4 million doses of AstraZeneca’s COVID-19 vaccine that it is not using to Mexico and Canada in loan deals with the two countries, an administration official told Reuters on…

IJRAnthropic CEO Urges Industry To Pace Itself Following String Of Runaway, Close-Call IncidentsSpencer Lombardo · 5 min · 11h

AstraZeneca Resumes UK Trials of COVID-19 Vaccine Halted by Patient IllnessReporting — Sep 13, 2020AstraZeneca <AZN.L> has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. The late-stage…

AstraZeneca Pauses Coronavirus Vaccine Trial, Rollout Doubts Dent SharesReporting — Sep 9, 2020AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares on Wednesday as the move was seen as dimming prospects…

US Secures 300 Million Doses of Potential Astrazeneca COVID-19 VaccineReporting — May 21, 2020The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca’s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their…

Ascelia Completes FDA Meeting on OrviglanceHealth — 4dBiopharma firms report a mix of regulatory progress: Ascelia Pharma advances its Orviglance NDA with an FDA Type A meeting held and minutes due in about 30 days, while AstraZeneca secures FDA approval for Etcamah (camizestrant) after an advisory panel opposed it earlier, signaling a potential shift in benefit-risk assessment. Ascletis Pharma launches a US Phase I trial for ASC36 obesity drug under an IND, highlighting ongoing development in metabolism therapies alongside expectations of further data and pricing implications for investors.

Tezspire meets Phase 3 endpoints in eosinophilic esophagitisHealth — Aug 27, 2026AstraZeneca and Amgen's Tezspire met its primary and secondary endpoints in the Phase 3 CROSSING trial for eosinophilic esophagitis, with improvements in histologic remission and reduced dysphagia sustained through week 52. The results bolster Tezspire’s potential as a multi-indication biologic across epithelial-driven inflammatory diseases, building on existing approvals for severe asthma and chronic rhinosinusitis with nasal polyps.

On X · @LYKNofficialLYKN “Oh My Gosh” MV Teaser ReactionsAnnouncement of LYKN’s “หน้าไหว้หลังหลอก (Oh My Gosh)” music video release on 15 Sep 2026 generated strong one-sided positive fan engagement and hype with no meaningful opposition or split.1,548 likes · 8m

Video — YouTubeA 9/11 Survivor Finally Shares the Story She Kept Private for 25 YearsSmartHER News · 6M views · Sep 10, 2026